Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review

Genes

Ryan D. Martin¹  Ryszard Kubinski¹  Kamila Majidova¹  Kamran Kafi¹  Julia Handfield¹ 

[1] Phyla Technologies Inc., Montréal, QC H3C 4J9, Canada;

关键词: inflammatory bowel disease (IBD);    Crohn’s disease (CD);    ulcerative colitis (UC);    digital health (DH);    artificial intelligence (AI);    diagnosis;   

DOI  :  10.3390/genes12101465

来源: DOAJ

【 摘 要 】

Inflammatory bowel diseases (IBD), subdivided into Crohn’s disease (CD) and ulcerative colitis (UC), are chronic diseases that are characterized by relapsing and remitting periods of inflammation in the gastrointestinal tract. In recent years, the amount of research surrounding digital health (DH) and artificial intelligence (AI) has increased. The purpose of this scoping review is to explore this growing field of research to summarize the role of DH and AI in the diagnosis, treatment, monitoring and prognosis of IBD. A review of 21 articles revealed the impact of both AI algorithms and DH technologies; AI algorithms can improve diagnostic accuracy, assess disease activity, and predict treatment response based on data modalities such as endoscopic imaging and genetic data. In terms of DH, patients utilizing DH platforms experienced improvements in quality of life, disease literacy, treatment adherence, and medication management. In addition, DH methods can reduce the need for in-person appointments, decreasing the use of healthcare resources without compromising the standard of care. These articles demonstrate preliminary evidence of the potential of DH and AI for improving the management of IBD. However, the majority of these studies were performed in a regulated clinical environment. Therefore, further validation of these results in a real-world environment is required to assess the efficacy of these methods in the general IBD population.

【 授权许可】

Unknown